Thermo Fisher Scientific, a diversified life science company, has announced its intent to purchase PPD, a Clinical Research Organization (CRO), for $17B. PPD is a publicly traded CRO and is the third largest CRO in terms of ongoing trials. PPD will be part of Thermo
